WST - West Pharmaceutical Services, Inc.
| Previous Close | 103.83 |
| Open | 104.39 |
| Bid | 0.00 x 1300 |
| Ask | 0.00 x 900 |
| Day's Range | 103.48 - 104.61 |
| 52 Week Range | 82.74 - 125.09 |
| Volume | 338,362 |
| Avg. Volume | 456,036 |
| Market Cap | 7.725B |
| Beta (3Y Monthly) | 1.37 |
| PE Ratio (TTM) | 38.06 |
| EPS (TTM) | 2.74 |
| Earnings Date | Feb 13, 2019 - Feb 18, 2019 |
| Forward Dividend & Yield | 0.60 (0.59%) |
| Ex-Dividend Date | 2019-01-22 |
| 1y Target Est | 111.17 |
- GlobeNewswire•3 days ago
Detailed Research: Economic Perspectives on The J. M. Smucker, West Pharmaceutical Services, Franklin Electric Co., Accenture, LiveXLive Media, and Otter Tail — What Drives Growth in Today's Competitive Landscape
NEW YORK, Feb. 21, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- PR Newswire•3 days ago
West Announces Quarterly Dividend and Share Repurchase Program
EXTON, Pa. , Feb. 21, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a second-quarter 2019 dividend of $0.15 per ...
- Thomson Reuters StreetEvents•3 days ago
Edited Transcript of WST earnings conference call or presentation 14-Feb-19 2:00pm GMT
Q4 2018 West Pharmaceutical Services Inc Earnings Call
- Zacks•10 days ago
West Pharmaceutical Services (WST) Beats Q4 Earnings Estimates
West Pharmaceutical (WST) delivered earnings and revenue surprises of 1.39% and -2.87%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•10 days ago
West Pharmaceutical: 4Q Earnings Snapshot
On a per-share basis, the Exton, Pennsylvania-based company said it had net income of 69 cents. Earnings, adjusted for pretax expenses and restructuring costs, were 73 cents per share. The results topped ...
- PR Newswire•10 days ago
West Announces Fourth-Quarter and Full-Year 2018 Results
- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 14, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter ...
- Markit•16 days ago
See what the IHS Markit Score report has to say about West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc NYSE:WSTView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is low for WST with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding WST totaled $2.96 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Industrials sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Zacks•17 days ago
West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy?
West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.•23 days ago
Could West Pharmaceutical Services, Inc.’s (NYSE:WST) Investor Composition Influence The Stock Price?
Want to participate in a short research study? Help shape the future of investing tools and receive a $60 prize! Every investor in West Pharmaceutical Services, Inc. (NYSE:WST) should be Read More...
- PR Newswire•24 days ago
West to Host Fourth-Quarter and Full-Year 2018 Conference Call
EXTON, Pa., Jan. 31, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2018 financial results before the market opens on Thursday, February 14, 2019, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. The conference ID is 2287302. An online archive of the broadcast will be available at the West website three hours after the live call and through Thursday, February 21, 2019, by dialing 855-859-2056 (U.S.) or 404-537-3406 (International).
- Motley Fool•29 days ago
3 Pick-and-Shovel Biotechnology Stocks
These biotech suppliers have performed extremely well for investors. Here's why each of them is poised for prosperity.
- Simply Wall St.•2 months ago
Does West Pharmaceutical Services, Inc.’s (NYSE:WST) CEO Pay Matter?
In 2015 Eric Green was appointed CEO of West Pharmaceutical Services, Inc. (NYSE:WST). First, this article will compare CEO compensation with compensation at similar sized companies. After that, we will Read More...
- Insider Monkey•2 months ago
West Pharmaceutical Services Inc. (WST): Are Hedge Funds Right About This Stock?
The market has been volatile as the Federal Reserve continues its rate hikes to normalize the interest rates. Small cap stocks have been hit hard as a result, as the Russell 2000 ETF (IWM) has underperformed the larger S&P 500 ETF (SPY) by about 4 percentage points through November 16th. SEC filings and hedge fund […]
- PR Newswire•2 months ago
West Announces Quarterly Dividend and Participation in Upcoming Investor Conference
EXTON, Pa. , Dec. 18, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2019 dividend of $0.15 per ...
- Simply Wall St.•3 months ago
West Pharmaceutical Services Inc (NYSE:WST): What’s In It For The Shareholders?
Two important questions to ask before you buy West Pharmaceutical Services Inc (NYSE:WST) is, how it makes money and how it spends its cash. What is left after investment, determines Read More...
- Simply Wall St.•3 months ago
Is Now The Time To Look At Buying West Pharmaceutical Services Inc (NYSE:WST)?
West Pharmaceutical Services Inc (NYSE:WST), which is in the medical equipment business, and is based in United States, received a lot of attention from a substantial price movement on the Read More...
- Zacks•4 months ago
HSIC vs. WST: Which Stock Is the Better Value Option?
HSIC vs. WST: Which Stock Is the Better Value Option?
- Thomson Reuters StreetEvents•4 months ago
Edited Transcript of WST earnings conference call or presentation 25-Oct-18 1:00pm GMT
Q3 2018 West Pharmaceutical Services Inc Earnings Call
- PR Newswire•4 months ago
West Announces Participation in Upcoming November Investor Conferences
EXTON, Pa. , Nov. 1, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management ...
